SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Meridian Bioscience Q2 EPS $0.230 Beats $0.080 Estimate, Sales $57.300M Beat $49.260M Estimate

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.230 per share which beat the analyst consensus estimate of $0.080 by 187.5 percent. This is a 21.05 percent increase over earnings of $0.190 per share

Benzinga · 05/08/2020 11:36

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.230 per share which beat the analyst consensus estimate of $0.080 by 187.5 percent. This is a 21.05 percent increase over earnings of $0.190 per share from the same period last year. The company reported quarterly sales of $57.300 million which beat the analyst consensus estimate of $49.260 million by 16.32 percent. This is a 14.03 percent increase over sales of $50.248 million the same period last year.